Drawing for HFCAS12MAX

USPTO serial 79402170

HFCAS12MAX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEVERSON, JUSTIN
Law office
TMO LAW OFFICE 111

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HFCAS12MAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Szymon Gurda

Szymon Gurda Cherskov Flaynik & Gurda, LLC903 Commerce DrSuite 310Oak Brook, IL 60523

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes; diagnostic preparations for medical or veterinary purposes; reagents for use in medical genetic testing; vaccines; medicines for human purposes for treating genetic diseases; biochemical medicines for treating genetic diseases; bulk drugs being pharmaceutical preparations for treating genetic diseases; injectable medicinal solutions for treating genetic diseases; pharmaceutical preparations for treating genetic diseases; chemical preparations for medical purposes for treating genetic diseases; chemical preparations for pharmaceutical purposes for treating genetic diseases; biological preparations for medical purposes for treating genetic diseases; drugs for medical purposes being pharmaceutical preparations for treating genetic diseases; chemico-pharmaceutical preparations for treating genetic diseases.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 17, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 17, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 29, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 14, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 14, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 5, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 5, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 5, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 29, 2024RFNTREFUSAL PROCESSED BY IB—
Dec 6, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 6, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 22, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 20, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2024DOCKASSIGNED TO EXAMINER—
Oct 25, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 21, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 21, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 15, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance